Cannmed announced as a finalist at the World CBD Awards for Best CBD White Label BrandCanndid announced as a finalist…
3,000 Tests and appointments completed since June 1st add to increased revenue across divisionsVANCOUVER, BC / ACCESSWIRE / June 13,…
Martin Sumichrast resigns as CEO, Board MemberCharlotte, North Carolina--(Newsfile Corp. - June 13, 2022) - cbdMD, Inc. (NYSE American: YCBD)…
Founder and current CEO Joseph E. Meehan will assume new role as CENTR's Founder and Board Chairman. Founder and current…
Innovaccer’s remote patient monitoring has been recognized by AVIA Connect for its role in advancing virtual acute care solutions to…
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced femtosecond laser…
GENEVA, SWITZERLAND / ACCESSWIRE / June 13, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to…
In final ELIANA analysis, 55% of patients with relapsed or refractory (r/r) B-cell acute lymphoblastic leukemia (ALL) who were treated…
-70% overall response rate (ORR) and 30% complete response (CR) rate in peripheral T-cell lymphoma (PTCL) and cutaneous T cell…
Media Release COPENHAGEN, Denmark; June 11, 2022 Epcoritamab demonstrated clinically meaningful efficacy in challenging to treat, highly refractory LBCL patients,…